Sign in
4

Changes in Ownership

bioAffinity Technologies, Inc. Filed Acc 0001493152-23-023817

President, CEO acquired 54,570 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Zannes Maria · President, CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-01 Grant or award : show line 1 in the form +8,227 $2.28 $18,758 69,895 D
2023-04-15 Grant or award : show line 2 in the form +9,920 $1.89 $18,749 79,815 D
2023-06-06 Grant or award : show line 3 in the form +26,178 $1.91 $50,000 105,993 D
2023-07-01 Grant or award : show line 4 in the form +10,245 $1.83 $18,748 116,238 D
Loading xslF345X04/ownership.xml…